$AKTX Akari Therapeutics Plc Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Akari Therapeutics Plc.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Akari Therapeutics Plc. Insider overview, share value development, latest insider transactions and email notifications about new events in Akari Therapeutics Plc for free.

CIK Number: 0001541157
IRS Number: 981034922
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: AKTX
Company Address: 24 WEST 40TH STREET 8TH FLOOR NEW YORK 10018
Phone number: +44 20 8004 0270
Former name: Morria Biopharmaceuticals PLC, date of change: 2012-02-01
Former name: Celsus Therapeutics Plc., date of change: 2013-06-21

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. The company was founded on October 7, 2004 and is headquartered in London, the United Kingdom.

Market Capitalization: $82.90M
Prev close: $7.00
Average Daily Volume: 2,231
Days Low: $7.00
Year Low: $6.71
Year High: $19.75

Akari Therapeutics Plc Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 30 2016AKTXAkari Therapeutics ...Cohen Mark SDirectorOption ExerciseA0.151,300,000189,0201,300,000
Jun 30 2016AKTXAkari Therapeutics ...Byrne DavidDirectorOption ExerciseA0.151,300,000189,0201,300,000
Jun 30 2016AKTXAkari Therapeutics ...Hill JamesDirectorOption ExerciseA0.151,300,000189,0201,300,000
Jun 30 2016AKTXAkari Therapeutics ...Ungar StuartDirectorOption ExerciseA0.151,300,000189,0201,300,000
Jun 30 2016AKTXAkari Therapeutics ...Williams Donald AllenDirectorOption ExerciseA0.151,300,000189,0201,300,000
Jun 30 2016AKTXAkari Therapeutics ...Williams Donald AllenDirectorOption ExerciseA0.151,300,000189,0201,300,000
Apr 26 2016AKTXAkari Therapeutics ...Byrne DavidDirectorOption ExerciseA17.961,300,00023,348,0001,300,000
Mar 25 2016AKTXAkari Therapeutics ...SHAW ROBERT MGeneral Counsel and ...Option ExerciseA14.101,800,00025,380,0001,800,000
Nov 25 2015AKTXAkari Therapeutics ...Ungar StuartDirectorOption ExerciseA0.191,088,722208,7081,088,722
Nov 25 2015AKTXAkari Therapeutics ...Hill JamesDirectorOption ExerciseA0.191,068,722204,8741,068,722
Nov 25 2015AKTXAkari Therapeutics ...Shaw AllanDirectorOption ExerciseA0.191,068,722204,8741,068,722
Nov 25 2015AKTXAkari Therapeutics ...Cohen Mark SDirectorOption ExerciseA0.191,028,722197,2061,028,722
Sep 23 2015AKTXAkari Therapeutics ...Shaw AllanDirectorOption ExerciseA0.32186,27860,000186,278
Sep 23 2015AKTXAkari Therapeutics ...Shaw AllanDirectorOption ExerciseA0.3245,00014,49545,000
Sep 23 2015AKTXAkari Therapeutics ...Hill JamesDirectorOption ExerciseA0.32231,27874,495231,278

View all Akari Therapeutics Plc insider transactions.